Metropolitan Life Insurance CO Avrobio, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.45 - $6.05 $10,732 - $18,821	-3,111 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$5.53 - $9.28 $17,203 - $28,870	3,111 New	3,111 $17,000
Q3 2021 Mar 30, 2023	SELL	$5.53 - $9.28 $37,714 - $63,289	-6,820 Reduced 68.67%	3,111 $17,000
Q3 2021 Nov 15, 2021	SELL	$5.53 - $9.28 $37,714 - $63,289	-6,820 Reduced 68.67%	3,111 $17,000
Q2 2021 Jun 21, 2023	BUY	$7.84 - $12.6 $77,859 - $125,130	9,931 New	9,931 $88,000
Q2 2021 Mar 30, 2023	BUY	$7.84 - $12.6 $9,149 - $14,704	1,167 Added 13.32%	9,931 $88,000
Q2 2021 Aug 16, 2021	BUY	$7.84 - $12.6 $77,788 - $125,017	9,922 Added 110244.44%	9,931 $88,000
Q1 2021 Jun 26, 2023	BUY	$10.54 - $19.3 $92,372 - $169,145	8,764 New	8,764 $111 Million
Q1 2021 Mar 30, 2023	SELL	$10.54 - $19.3 $12,342 - $22,600	-1,171 Reduced 11.79%	8,764 $111,000
Q1 2021 May 14, 2021	SELL	$10.54 - $19.3 $104,620 - $191,571	-9,926 Reduced 99.91%	9 $111,000
Q4 2020 Jun 22, 2023	BUY	$12.79 - $17.1 $127,068 - $169,888	9,935 New	9,935 $138,000
Q3 2020 Jun 26, 2023	BUY	$12.99 - $19.41 $129,055 - $192,838	9,935 New	9,935 $129,000
Q2 2020 Jun 26, 2023	BUY	$12.19 - $22.96 $121,107 - $228,107	9,935 New	9,935 $173,000
Q2 2020 Mar 30, 2023	BUY	$12.19 - $22.96 $30,828 - $58,065	2,529 Added 34.15%	9,935 $173,000
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $30,828 - $58,065	2,529 Added 34.15%	9,935 $173,000
Q1 2020 Jul 12, 2023	BUY	$10.08 - $27.21 $78,089 - $210,795	7,747 New	7,747 $120,000
Q1 2020 Mar 30, 2023	BUY	$10.08 - $27.21 $12,549 - $33,876	1,245 Added 20.21%	7,406 $115,000
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $12,549 - $33,876	1,245 Added 20.21%	7,406 $115,000
Q4 2019 Jul 12, 2023	BUY	$13.05 - $21.88 $80,401 - $134,802	6,161 New	6,161 $124,000
Q3 2019 Jul 12, 2023	BUY	$14.12 - $23.44 $86,993 - $144,413	6,161 New	6,161 $86,000
Q3 2019 Mar 30, 2023	BUY	$14.12 - $23.44 $86,993 - $144,413	6,161 New	6,161 $86,000
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $86,993 - $144,413	6,161 New	6,161 $87,000
Q2 2019 Jul 12, 2023	BUY	$13.21 - $27.29 $17,754 - $36,677	1,344 New	1,344 $21.9 Million
Q4 2018 Feb 14, 2019	SELL	$15.43 - $32.7 $12,359 - $26,192	-801 Closed	0 $0
Q3 2018 Jul 13, 2023	BUY	$26.95 - $52.7 $98,583 - $192,776	3,658 New	3,658 $190 Million
Q3 2018 Nov 14, 2018	BUY	$26.95 - $52.7 $21,586 - $42,212	801 New	801 $42,000

Others Institutions Holding AVRO

# of Institutions

Shares Held

559K

Call Options Held

Put Options Held

Terrapin Asset Management, LLC Miami, FL

559K
Shares

$0
0.98% of portfolio

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account